‘New’ GSK spotlights growth potential of vaccines and speciality medicines
British drugmaker predicted a substantial £33bn sales ambition by 2031 in investor update
Read More
Tag: investor update
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
